Literature DB >> 8836754

Effect of clot removal on cerebrovascular contraction after subarachnoid hemorrhage in the monkey: pharmacological study.

T Tsuji1, D A Cook, B K Weir, Y Handa.   

Abstract

Clot removal at early surgery has been reported to be clinically effective for the prevention of cerebral vasospasm following subarachnoid hemorrhage (SAH) due to rupture of an intracranial aneurysm. We examined the most efficacious timing of mechanical clot removal on pharmacological responses in a monkey SAH model. Cynomolgus monkeys (Macaca fascicularis) were randomized into five groups: sham-operated, clot removal in which the clot was removed 48, 72, or 96 h after SAH, and clot groups. An autologous blood clot was placed around the bilateral major cerebral arteries after craniectomy to mimic the hemorrhage. Seven days after the SAH, proximal and successively distal parts of the middle cerebral arteries were cut into rings for isometric tension measurement. The contractile responses to potassium chloride, 5-hydroxytryptamine, norepinephrine, adenosine triphosphate, prostaglandin F20, and hemoglobin were greater in the proximal parts than in the distal parts in each group. Compared with the sham-operated group, the responses of the clot-removal and clot groups to the drugs were progressively attenuated. The maximum responses to 5-hydroxytryptamine in the proximal parts and to adenosine triphosphate in the distal parts started to decrease, significantly, in the clot-removal group 48 h after SAH, while most of the responses to the other agonists began to decrease in the clot-removal groups later than 72 h after SAH. These results suggest that the attenuation of cerebrovascular contractile responses 7 days after SAH is pharmacologically inevitable, even if the clot is removed as early as 48 h after the SAH. Clot removal may thus be recommended within 48h after SAH to ameliorate the severity of cerebral vasospasm following SAH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836754     DOI: 10.1007/bf01744506

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  42 in total

1.  Cytoskeletal and extracellular matrix proteins in cerebral arteries following subarachnoid hemorrhage in monkeys.

Authors:  R L Macdonald; B K Weir; J D Young; M G Grace
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

2.  The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results.

Authors:  N F Kassell; J C Torner; J A Jane; E C Haley; H P Adams
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

3.  Reactivity of rabbit basilar artery to alterations in extracellular potassium and calcium after subarachnoid hemorrhage.

Authors:  H A Young; R C Kolbeck; H Schmidek; J N Evans
Journal:  Neurosurgery       Date:  1986-09       Impact factor: 4.654

4.  A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings.

Authors:  F Espinosa; B Weir; T Shnitka; T Overton; D Boisvert
Journal:  J Neurosurg       Date:  1984-06       Impact factor: 5.115

5.  Impairment of endothelium-dependent vasodilation induced by acetylcholine and adenosine triphosphate following experimental subarachnoid hemorrhage.

Authors:  T Nakagomi; N F Kassell; T Sasaki; S Fujiwara; R M Lehman; J C Torner
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

6.  Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.

Authors:  V G Varsos; T M Liszczak; D H Han; J P Kistler; J Vielma; P M Black; R C Heros; N T Zervas
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

7.  Surgical manipulation of primate cerebral arteries in established vasospasm.

Authors:  J M Findlay; R L Macdonald; B K Weir; M G Grace
Journal:  J Neurosurg       Date:  1991-09       Impact factor: 5.115

8.  Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.

Authors:  J M Findlay; B K Weir; N F Kassell; L B Disney; M G Grace
Journal:  J Neurosurg       Date:  1991-08       Impact factor: 5.115

9.  Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage.

Authors:  R D Lobato; J Marín; M Salaices; F Rivilla; J Burgos
Journal:  J Neurosurg       Date:  1980-10       Impact factor: 5.115

10.  Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs.

Authors:  Y Kajita; Y Suzuki; H Oyama; T Tanazawa; M Takayasu; M Shibuya; K Sugita
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

View more
  4 in total

1.  Cerebral vasospasm after aneurysmal subarachnoid hemorrhage and traumatic brain injury.

Authors:  Saef Izzy; Susanne Muehlschlegel
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

Review 2.  Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Jean G de Oliveira; Jürgen Beck; Christian Ulrich; Julian Rathert; Andreas Raabe; Volker Seifert
Journal:  Neurosurg Rev       Date:  2006-10-24       Impact factor: 3.042

Review 3.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

4.  Aneurysmal subarachnoid hemorrhage models: do they need a fix?

Authors:  Fatima A Sehba; Ryszard M Pluta
Journal:  Stroke Res Treat       Date:  2013-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.